Cannabis in the Treatment of Pediatric Epilepsy Bonni Goldstein, MD (2015)

CBD Enriched Medical Cannabis for Intractable Pediatric Epilepsy European Journal of Epilepsy (2016)

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use Epilepsy & Behavior (2017)

First Canadian paediatric study of mixed THC/CBD cannabis oil shows promise for children with drug-resistant epilepsy SickKids (2018)

Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada Canadian League Against Epilepsy Medical Therapeutics Committee (2019)

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects Neuropsychiatric Disease and Treatment (2020)

Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study Frontiers in Pharmacology (2020)

An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy Cannabis and Cannabinoid Research (2020)

The long-term efficacy of cannabidiol in the treatment of refractory epilepsy International League Against Epilepsy (2021)

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials Epilepsia (2021)

Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study CNS Drugs (2021)

Long-term use of cannabidiol-enriched medical cannabis in a prospective cohort of children with drug-resistant developmental and epileptic encephalopathy European Journal of Epilepsy (2022)

Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies Experimental Neurology (2023)